Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03LZO
|
|||
Drug Name |
PMID27376512-Compound-Figure3CG
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
PIERRE FABRE MEDICAMENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
|
|||
Structure |
Download2D MOL |
|||
Formula |
C34H38N6O
|
|||
Canonical SMILES |
C1CN(CCC1COC2=CC3=C(C=C2)C(=NC=N3)NCCCC4=CC=CC=C4)CCNC5=CC=NC6=CC=CC=C65
|
|||
InChI |
1S/C34H38N6O/c1-2-7-26(8-3-1)9-6-17-37-34-30-13-12-28(23-33(30)38-25-39-34)41-24-27-15-20-40(21-16-27)22-19-36-32-14-18-35-31-11-5-4-10-29(31)32/h1-5,7-8,10-14,18,23,25,27H,6,9,15-17,19-22,24H2,(H,35,36)(H,37,38,39)
|
|||
InChIKey |
DPNGRMNVFKZZSM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | DNA [cytosine-5]-methyltransferase 3A (DNMT3A) | Target Info | Inhibitor | [1] |
Target's Patent Info | DNA [cytosine-5]-methyltransferase 3A (DNMT3A) | Target's Patent Info | [1] | |
KEGG Pathway | Cysteine and methionine metabolism | |||
Metabolic pathways | ||||
MicroRNAs in cancer |
References | Top | |||
---|---|---|---|---|
REF 1 | DNA methyltransferase inhibitors: an updated patent review (2012-2015).Expert Opin Ther Pat. 2016 Sep;26(9):1017-30. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.